Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

IL-17 integrates multiple self-reinforcing, feed-forward mechanisms through the RNA binding protein Arid5a.

Amatya N, Childs EE, Cruz JA, Aggor FEY, Garg AV, Berman AJ, Gudjonsson JE, Atasoy U, Gaffen SL.

Sci Signal. 2018 Oct 9;11(551). pii: eaat4617. doi: 10.1126/scisignal.aat4617.

2.

Arid5a stabilizes OX40 mRNA in murine CD4+ T cells by recognizing a stem-loop structure in its 3'UTR.

Hanieh H, Masuda K, Metwally H, Chalise JP, Mohamed M, Nyati KK, Standley DM, Li S, Higa M, Zaman MM, Kishimoto T.

Eur J Immunol. 2018 Apr;48(4):593-604. doi: 10.1002/eji.201747109. Epub 2018 Feb 5.

3.

Arid5a controls IL-6 mRNA stability, which contributes to elevation of IL-6 level in vivo.

Masuda K, Ripley B, Nishimura R, Mino T, Takeuchi O, Shioi G, Kiyonari H, Kishimoto T.

Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):9409-14. doi: 10.1073/pnas.1307419110. Epub 2013 May 15.

4.

Arid5a exacerbates IFN-γ-mediated septic shock by stabilizing T-bet mRNA.

Zaman MM, Masuda K, Nyati KK, Dubey PK, Ripley B, Wang K, Chalise JP, Higa M, Hanieh H, Kishimoto T.

Proc Natl Acad Sci U S A. 2016 Oct 11;113(41):11543-11548. Epub 2016 Sep 26.

5.

TLR4-induced NF-κB and MAPK signaling regulate the IL-6 mRNA stabilizing protein Arid5a.

Nyati KK, Masuda K, Zaman MM, Dubey PK, Millrine D, Chalise JP, Higa M, Li S, Standley DM, Saito K, Hanieh H, Kishimoto T.

Nucleic Acids Res. 2017 Mar 17;45(5):2687-2703. doi: 10.1093/nar/gkx064.

6.

MCPIP1 Endoribonuclease Activity Negatively Regulates Interleukin-17-Mediated Signaling and Inflammation.

Garg AV, Amatya N, Chen K, Cruz JA, Grover P, Whibley N, Conti HR, Hernandez Mir G, Sirakova T, Childs EC, Smithgall TE, Biswas PS, Kolls JK, McGeachy MJ, Kolattukudy PE, Gaffen SL.

Immunity. 2015 Sep 15;43(3):475-87. doi: 10.1016/j.immuni.2015.07.021. Epub 2015 Aug 25.

7.

IκB-ζ Expression Requires Both TYK2/STAT3 Activity and IL-17-Regulated mRNA Stabilization.

Muromoto R, Tawa K, Ohgakiuchi Y, Sato A, Saino Y, Hirashima K, Minoguchi H, Kitai Y, Kashiwakura JI, Shimoda K, Oritani K, Matsuda T.

Immunohorizons. 2019 May 16;3(5):172-185. doi: 10.4049/immunohorizons.1900023.

PMID:
31356171
8.

Interleukin-17 (IL-17) and IL-1 activate translation of overlapping sets of mRNAs, including that of the negative regulator of inflammation, MCPIP1.

Dhamija S, Winzen R, Doerrie A, Behrens G, Kuehne N, Schauerte C, Neumann E, Dittrich-Breiholz O, Kracht M, Holtmann H.

J Biol Chem. 2013 Jun 28;288(26):19250-9. doi: 10.1074/jbc.M113.452649. Epub 2013 May 8.

9.

MCPIP1, alias Regnase-1 binds and cleaves mRNA of C/EBPβ.

Lipert B, Wilamowski M, Gorecki A, Jura J.

PLoS One. 2017 Mar 22;12(3):e0174381. doi: 10.1371/journal.pone.0174381. eCollection 2017.

10.

Regulation of inflammatory responses by dynamic subcellular localization of RNA-binding protein Arid5a.

Higa M, Oka M, Fujihara Y, Masuda K, Yoneda Y, Kishimoto T.

Proc Natl Acad Sci U S A. 2018 Feb 6;115(6):E1214-E1220. doi: 10.1073/pnas.1719921115. Epub 2018 Jan 22.

11.

Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF).

Sun D, Novotny M, Bulek K, Liu C, Li X, Hamilton T.

Nat Immunol. 2011 Aug 7;12(9):853-60. doi: 10.1038/ni.2081.

12.

A Potential Therapeutic Target RNA-binding Protein, Arid5a for the Treatment of Inflammatory Disease Associated with Aberrant Cytokine Expression.

Masuda K, Kishimoto T.

Curr Pharm Des. 2018;24(16):1766-1771. doi: 10.2174/1381612824666180426103753. Review.

PMID:
29701145
13.

Arid5a Regulation and the Roles of Arid5a in the Inflammatory Response and Disease.

Nyati KK, Agarwal RG, Sharma P, Kishimoto T.

Front Immunol. 2019 Dec 5;10:2790. doi: 10.3389/fimmu.2019.02790. eCollection 2019. Review.

14.

MCPIP1/Regnase-1 Restricts IL-17A- and IL-17C-Dependent Skin Inflammation.

Monin L, Gudjonsson JE, Childs EE, Amatya N, Xing X, Verma AH, Coleman BM, Garg AV, Killeen M, Mathers A, Ward NL, Gaffen SL.

J Immunol. 2017 Jan 15;198(2):767-775. doi: 10.4049/jimmunol.1601551. Epub 2016 Dec 5.

15.

IL-17-receptor-associated adaptor Act1 directly stabilizes mRNAs to mediate IL-17 inflammatory signaling.

Herjan T, Hong L, Bubenik J, Bulek K, Qian W, Liu C, Li X, Chen X, Yang H, Ouyang S, Zhou H, Zhao J, Vasu K, Cockman E, Aronica M, Asosingh K, Licatalosi DD, Qin J, Fox PL, Hamilton TA, Driscoll D, Li X.

Nat Immunol. 2018 Apr;19(4):354-365. doi: 10.1038/s41590-018-0071-9. Epub 2018 Mar 21.

16.

Arid5a-deficient mice are highly resistant to bleomycin-induced lung injury.

Dubey PK, Masuda K, Nyati KK, -Uz Zaman MM, Chalise JP, Millrine D, Kai W, Ripley B, Kishimoto T.

Int Immunol. 2017 Feb 1;29(2):79-85. doi: 10.1093/intimm/dxx004.

PMID:
28379390
17.

The IκB kinase complex regulates the stability of cytokine-encoding mRNA induced by TLR-IL-1R by controlling degradation of regnase-1.

Iwasaki H, Takeuchi O, Teraguchi S, Matsushita K, Uehata T, Kuniyoshi K, Satoh T, Saitoh T, Matsushita M, Standley DM, Akira S.

Nat Immunol. 2011 Oct 30;12(12):1167-75. doi: 10.1038/ni.2137.

PMID:
22037600
18.

Arid5a makes the IL-17A/F-responsive pathway less arid.

Puel A, Casanova JL.

Sci Signal. 2018 Oct 9;11(551). pii: eaau8876. doi: 10.1126/scisignal.aau8876. Review.

PMID:
30301789
19.

IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-beta , NF-kappaB, and AP-1 activation.

Cortez DM, Feldman MD, Mummidi S, Valente AJ, Steffensen B, Vincenti M, Barnes JL, Chandrasekar B.

Am J Physiol Heart Circ Physiol. 2007 Dec;293(6):H3356-65. Epub 2007 Oct 5.

20.

Gain-of-Function Mutation of Card14 Leads to Spontaneous Psoriasis-like Skin Inflammation through Enhanced Keratinocyte Response to IL-17A.

Wang M, Zhang S, Zheng G, Huang J, Songyang Z, Zhao X, Lin X.

Immunity. 2018 Jul 17;49(1):66-79.e5. doi: 10.1016/j.immuni.2018.05.012. Epub 2018 Jul 3.

Supplemental Content

Support Center